Skip to content
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is […]
Putting Americans First: International prices in context Read More »
Putting Americans First: No medicine is more expensive than the one patients can’t access
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the
The biotech-focused provisions in the reconciliation bill prioritize R&D, patient affordability
The One Big Beautiful Bill Act – the “reconciliation bill” being considered by Congress – features policies that are crucial for driving American innovation.
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America
“This is America,” goes the musical refrain of the new Hims & Hers Super Bowl ad for its compounded obesity drugs. But Hims &
What the Hims & Hers Super Bowl commercial gets wrong about innovation… and America Read More »
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand the issue clearly. In
Combatting misinformation on biotechnology in food Read More »
Putting patients first: Workers suffer when their employers lack critical information about PBMs
This is the fifth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Access barriers to medicines plague 1 in 3 patients, new poll finds
Access to health insurance coverage doesn’t always mean patients have access to the health care services and medicines they need. A new poll, commissioned
Access barriers to medicines plague 1 in 3 patients, new poll finds Read More »
Putting patients first: Retail pharmacies—and the patients they serve—are being endangered by PBM Power
This is the fourth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Separating PBM compensation from prices Is critical in reducing patient financial burden
This is the third in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care
This is the second in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care Read More »